Analysis of facilitation of HERG current by a class III anti-arrhythmic agent, nifekalant

被引：0
|
作者：
Iwata, Miki
Hosaka, Yukio
Kamiya, Narutoshi
Kinoshita, Kengo
Inanobe, Atsushi
Nakamura, Haruki
Kurachi, Yoshihisa
机构：
[1] Osaka Univ, Sch Med, Dept Pharmacol, Div Mol Cell Pharmacol, Osaka 5650871, Japan
[2] Niigata Univ, Grad Sch Med & Dent Sci, Div Cardiol, Niigata 9508510, Japan
[3] Kobe Univ, Grad Sch Med, Dept CGI, Kobe, Hyogo 6500047, Japan
[4] Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan
[5] Osaka Univ, Inst Prot Res, Lab Prot Informat, Osaka 5650871, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2007年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：193P / 193P
页数：1
相关论文
共 50 条
  • [1] Mutational analysis of block and facilitation of HERG current by A class III anti-arrhythmic agent, nifekalant
    Hosaka, Yukio
    Iwata, Miki
    Kamiya, Narutoshi
    Yamada, Mitsuhiko
    Kinoshita, Kengo
    Fukunishi, Yoshifumi
    Tsujimae, Kenji
    Hibino, Hiroshi
    Aizawa, Yoshifusa
    Inanobe, Atsushi
    Nakamura, Haruki
    Kurachi, Yoshihisa
    CHANNELS, 2007, 1 (03) : 198 - 208
  • [2] Mechanism underlying the facilitation of hERG current by class III anti-arrhythmic agents
    Inanobe, Atsushi
    Furutani, Kazuharu
    Iwata, Miki
    Kurachi, Yoshihisa
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 69P - 69P
  • [3] Anti-arrhythmic efficacy of nifekalant hydrochloride, a pure class III anti-arrhythmic agent, in patients with healed myocardial infarction and inducible sustained ventricular tachycardia
    Igawa, M
    Aonuma, K
    Okamoto, Y
    Hiroe, M
    Hiraoka, T
    Isobe, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2002, 40 (05) : 733 - 740
  • [4] Effect of nifekalant, a class III anti-arrhythmic agent, on Ca2+ waves in rat intact trabeculae
    Hirose, M
    Miura, M
    Wakayama, Y
    Endo, H
    Sugai, Y
    Stuyvers, BDMY
    Kagaya, Y
    Watanabe, J
    ter Keurs, HEDJ
    Shirato, K
    CIRCULATION JOURNAL, 2005, 69 (06) : 739 - 745
  • [5] EFFECTS OF CLASS III ANTI-ARRHYTHMIC AGENTS WITH HERG CHANNEL BLOCK AND FACILITATION ON CARDIAC ACTION POTENTIAL: A SIMULATION STUDY
    Furutani, K.
    Tsumoto, K.
    Chen, I.
    Kurachi, Y.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 23 - 23
  • [6] Azimilide dihydrochloride: a new class III anti-arrhythmic agent
    Abrol, R
    Page, RL
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (11) : 2705 - 2715
  • [7] DRUGS WITH A CLASS III ANTI-ARRHYTHMIC ACTION
    BEXTON, RS
    CAMM, AJ
    PHARMACOLOGY & THERAPEUTICS, 1982, 17 (03) : 315 - 355
  • [8] New aminocarboxamides with class III anti-arrhythmic activity
    Poppe, H
    Schindler, R
    Sauer, W
    Marx, D
    Bartsch, R
    Kaverina, NV
    Lichoscherstow, AM
    Sokolov, SF
    Lyskovtsev, VV
    Seredenin, SB
    Borisenko, SA
    ARCHIV DER PHARMAZIE, 1999, 332 (07) : 233 - 242
  • [9] D-SOTALOL - A NEW POTENT CLASS-III ANTI-ARRHYTHMIC AGENT
    TAGGART, P
    SUTTON, P
    DONALDSON, R
    CLINICAL SCIENCE, 1985, 69 (05) : 631 - 636
  • [10] Comparison of inhibitory effects on HERG potassium channels of the class Ic anti-arrhythmic agent flecainide with the class la agent quinidine and class Ib agent lignocaine
    Paul, AA
    Witchel, HJ
    Hancox, JC
    JOURNAL OF PHYSIOLOGY-LONDON, 2001, 536 : 78P - 79P
12345